Nitric oxide - The endothelium-derived relaxing factor and its role in endothelial functions

General Physiology and Biophysics

Volumn 29, Issue 4, 2010, Pages 319-340

  Bauer, Viktor ^a   Sotníková, Růžena ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Angiotensin; Diabetes; Endotheliopathies; Endothelium; Endothelium derived factors; Ischemia reperfusion; Lipid peroxidation

Indexed keywords

ACETYLCHOLINE; ADENOSINE MONOPHOSPHATE DEAMINASE; ANGIOTENSIN I; ANGIOTENSIN II; CALCIUM; CALMODULIN; COPPER ZINC SUPEROXIDE DISMUTASE; DIACYLGLYCEROL; DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE TRANSPORTER 4; GUANYLATE CYCLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; INSULIN RECEPTOR SUBSTRATE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROSTAGLANDIN; SERINE; THREONINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CALCIUM CELL LEVEL; CARDIOVASCULAR RISK; CELL CYCLE; CELL FUNCTION; DIABETES MELLITUS; DRUG MECHANISM; ECLAMPSIA; ENDOTHELIAL DYSFUNCTION; ENZYME SYNTHESIS; HEART PROTECTION; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; ISCHEMIA; MUSCLE CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERFUSION AND SUPERFUSION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BLOOD VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASODILATION;

EID: 78650631727     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_04_319     Document Type: Review

References (243)

1. Achan V., Broadhead M., Malaki M., Whitley G., Leiper J., MacAllister R., Vallance P. (2003): Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler. Thromb. Vase. Biol. 23, 1455-1459; doi:10.1161/01. ATV.0000081742.92006.59
2. Adams D. J., Rusko J., Van Slooten G. (1993): Calcium signalling in vascular endothelial cells, Ca2+ entry and release. In: Ion Flux in Pulmonary Vascular Control. (Ed. E. K. Weir), pp. 259-275, Plenum Press, New York
3. Alderton W. K., Cooper C. E., Knowles R. G. (2001): Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615; doi:10.1042/0264-6021:3570593
4. Andersen K., Pedersen B. K. (2008): The role of inflammation in vascular insulin resistance with focus on IL-6. Horm. Metab. Res. 40,635-639; doi: 10.1055/s-0028-1083810
5. Anderson E. A., Mark A. L. (1989): Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 79, 93-100
6. Andrews N. P., Prasad A., Quyyumi A. A. (2001): N-acetylcysteine improves coronary and peripheral vascular function. J. Am. Coll. Cardiol. 37, 117-123; doi:10.1016/s0735-1097(00)01093-7
7. Aversa A., Bruzziches R., Francomano D., Natali M., Gareri P., Spera G. (2009): Endothelial dysfunction and erectile dysfunction in the aging man. Int. J. Urol. 17, 38-47; doi: 10.1111/j.1442-2042.2009.02426.x
8. Bakker W, Eringa E. C. Sipkema P., van Hinsbergh V. W. (2009): Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 335,165-189; doi:10.1007/s00441-008- 0685-6
9. Bauer P. M., Fulton D., Boo Y. C., Sorescu G. P., Kemp B. E., Jo H., Sessa W. C. (2003): Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J. Biol. Chem. 278,14841-14849; doi: 10.1074/ jbc.M211926200
10. Bauer V. (1993): NANC transmission in intestines and its pharmacological modulation. Acta Neurobiol. Exp. 53,65-77
11. Bauer V., GergeFD. (1994): Endothelium and reactive oxygen species. Bratisl. Med. J. 95,243-263
12. Bauer V., Nakajima T., Pucovský V., Onoue H., Ito Y. (2000): Effects of superoxide generating systems on muscle tone, cholinergic and NANC responses in cat airways. J. Autonom. Ner. System 79,34-44; doi:10.1016/S0165- 1838(99)00100-9
13. Baynes J. W. (1991): Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412; doi: 10.2337/diabetes.40.4.405
14. Beckman J. S., Koppenol W. H. (1996): Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424-1437
15. Beny J. L., Burnet P. C. (1988): Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilatation of pig coronary arteries. Blood Vessels 25, 308-311
16. Besler C., Doerries C., Giannotti G., Lüscher T. F., Landmesser U. (2008): Pharmacological approaches to improve endothelial repair mechanisms. Expert. Rev. Cardiovasc. Ther. 6, 1071-1082; doi:10.1586/14779072.6.8.1071
17. Blatter L. A., Wier W. G. (1994): Nitric oxide decreases (Ca2+)i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 15, 122-131; doi:10.1016/0143-4160(94)90051-5
18. Boeckstaens G. E., Bult H., Pelckmans P. A., Jordaens F. H., Hermen A. G., Marcke Y. M. (1990): Nitric oxide release in response to stimulation of nonadrenergic noncholinergic nerves. Arch. Int. Pharmacodyn. Ther. 305, 232-235
19. Booth A., Wallace S., McEniery C. M., Yasmin Brown J., Jayne D. R., Wilkinson I. B. (2004): Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis. Rheum. 50, 581-588; doi:100.1002/art.20002
20. Bratt J. M., Franzi L. M., Linderholm A. L., O'Roark E. M., Kenyon N. J., Last J. A. (2009): Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol. Appl. Pharmacol. 242, 1-8; doi:10.1016/j.taap.2009.09.018
21. Bredt D. S., Snyder S. H. (1990): Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682-685; doi:10.1073/pnas.87.2.682
22. Brouet A., Sonveaux P., Dessy C., Balligand J. L., Feron O. (2001): Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J. Biol. Chem. 276, 32663-32669; doi: 10.1074/jbc.M101371200
23. Buga G. M., Ignarro L. J. (1992): Electrical field stimulation causes endothelium-dependent and nitric oxide-mediated relaxation of pulmonary artery. Amer. J. Physiol. 262, H973-979
24. Bulhak A. A., Jung C., Ostenson C. G., Lundberg J. O., Sjöquist P. O., Pernow J. (2009): PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am. J. Physiol. Heart. Circ. Physiol. 296, H719-727; doi:10.1152/ajpheart.00394.2008
25. Busse R., Mülsch A. (1990): Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 256, 133-136; doi:10.1016/0014-5793(90)80902-U (Pubitemid 20189413)
26. Busse R., Fichtner H., Luckhoff A., Kolehortckt M. (1988): Hyperpolarization and increased free calcium in acetylcholine- stimulated endothelial cells. Amer. J. Physiol. 255, H965-969
27. Cai H., Harrison D. G. (2000): Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844
28. Carden D. L., Granger D. N. (2000): Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190, 255-266; doi: 10.1002/(SICI) 1096-9896(200002) 190:3<255:: AID-PATH526>3.0.CO;2-6
29. Carr A., Frei B. (2000): The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic. Biol. Med. 28, 1806-1814; doi:10.1016/S0891-5849(00)00225-2
30. Carvajal J. A., Germain A. M., Huidobro-Toro J. P., Weiner C. P. (2000): Molecular mechanism of cGMP-mediated smooth muscle relaxation. J. Cell Physiol. 184, 409-420; doi:10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K
31. Chatterjee A., Catravas J. D. (2008): Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul. Pharmacol. 49,134-140; doi:10.1016/j.vph.2008.06.008
32. Chien W. Y., Yang K. D., Eng H. L., Hu Y. H., Lee P. Y., Wang S. T., Wang P. W. (2005): Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance. Diabetes Metab. 31, 63-68; doi:10.1016/S1262-3636(07)70168-4
33. Chorianopoulos E., Bea F., Katus H. A., Frey N. (2009): The role of endothelial cell biology in endocarditis. Cell Tissue Res. 335,153-163; doi:10.1007/s00441-008-0687-4
34. Cleland S. J., Sattar N., Petrie J. R., Forouhi N. G., Elliott H. L., Connell J. M. C. (2000): Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin. Sei. (London) 98, 531-535; doi:10.1042/CS20000013
35. Collins P., Lewis M. J., Henderson A. H. (1988): Endothelium-derived factor relaxes vascular smooth muscle by cyclic GMP-mediated effects on calcium movements. In: Relaxing and Contracting Factors, Biological and Clinical Research (Eds. P. M. Vanhoutte, N. J. Clifton), pp. 267-283, Human Press, New York
36. Cooke J. P. (2005): ADMA: its role in vascular disease. Vasc. Med. 10, S1-2; doi:10.1191/1358863x05vm598oa
37. Cordes C. M., Bennett R. G., Siford G. L., Hamel F. G. (2009): Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Biochem. Pharmacol. 77, 1064-1073; doi:10.1016/j.bcp.2008.12. 006
38. Cryer A. (1998): Scale and diversity of interactions at the vascular endothelium. In: Biochemical Interactions at the Endothelium (Ed. D. G.), pp. 1-3, Pergamon Press, Oxford
39. Darley-Usmar V., Halliwell B. (1996): Blood Radicals. Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharmaceut. Res. 13, 649-662; doi:10.1023/A:1016079012214
40. Davies M. G., Hagen P. O. (1993): The vascular endothelium. A new horizon. Ann. Surg. 218,593-609; doi:10.1097/00000658-199321850-00003
41. De Jager J., Dekker J. M., Kooy A., Kostense P. J., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. (2006): Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the hoorn study. Arterioscler. Thromb. Vase. Biol. 26, 1086-1093; doi:10.1161/01.ATV.0000215951.36219.a4
42. DeMey J. G., Vanhoutte P. M. (1983): Anoxia and endothelium dependent reactivity in canine femoral artery. J. Physiol. (London) 335, 65-74
43. De Vriese A. S., Verbeuren T. J., van de Voorde J., Lameire N. H., Vanhoutte P. M. (2000): Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130, 963-974; doi:10.1038/sj.bjp.0703393
44. Di Corleto P. E., Chisalm G. M. (1986): Participation of the endothelium in the development of the atherosclerotic plaque. Prog. Lipid. Res. 25,365-374, doi:10.1016/0163-7827(86)90074-3
45. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A. M. (1999): Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605; doi:10.1038/21224 (Pubitemid 129623069)
46. Duffy S. J., Gokce N., Holbrook M., Hunter L. M., Biegelsen E. S., Huang A., Keaney J. F., Vita J. A. (2001): Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am. J. Physiol. Heart Circ. Physiol. 280, H528-534
47. Duprez D. A., Somasundaram P. E., Sigurdsson G., Hoke L., Florea N., Cohn J. N. (2005): Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J. Hum. Hypertens. 19, 515-519; doi:10.1038/sj.jhh.1001860
48. Ebrahimian T., Mathieu E., Silvestre J. S., Boulanger C. M. (2003): Intraluminal pressure increases vascular neuronal nitric oxide synthase expression. J. Hypertens. 21, 937-942; doi:10.1097/00004872-200305000-00018
49. Eisenberg P. R. (1991): Endothelial cell mediators of thrombosis and fibrinolysis: review in depth. Coronary Artery Dis. 2, 129-166; doi:10.1097/00019501-199104000-00001
50. Elliott D. (2008): Migraine and stroke: current perspectives. Neurol. Res. 30, 801-812; doi:10.1179/174313208X341049
51. Elliot S. J., Meszaros G. J., Schilling M. (1992): Effect of oxidant stress on calcium signaling in vascular endothelial cells. Free Rad. Biol. Med. 13, 635-650; doi:10.1016/0891-5849(92)90038-1
52. Esterbauer H., Rotleneder M., Striegl G. (1989): Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat. Sci. Technol. 91, 316-324
53. Evcimen D. N., King G. L. (2007): The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol. Res. 55, 498-510; doi:10.1016/j.phrs.2007.04.016
54. Félétou M., Köhler R., Vanhoutte P.M. (2010): Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr. Hypertens. Rep. 12, 267-275; doi:10.1007/s11906-010-0118-2
55. Feron O., Belhassen L., Kobzik L., Smith T. W., Kelly R. A., Michel T. (1996): Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271, 22810-22814; doi:10.1074/jbc.271.37.22810
56. Ferrario C. M. (1993): Biological roles of angiotensin-(1-7). Hypertension Res. 72, 239-245
57. Fichtischerer S., Rossig L., Breuer S., Vasa M., Dimmeler S., Zeiher A. M. (2001): Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 104, 3023-3025; doi:10.1161/hc5001.101749 (Pubitemid 34014050)
58. Florey L. (1966): The endothelial cell. Brit. Med. J. (Clin. Res.) 2, 487-490
59. Fowler M. J. (2008): Microvascular and macrovascular complications of diabetes. Clin. Diab. 26, 77-82; doi:10.2337/diaclin.26.2.77
60. Fontana J., Fulton D., Chen Y., Fairchild T. A., McCabe T. J., Fujita N., Tsuruo T., Sessa W. C. (2002): Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ. Res. 90, 866-873; doi:10.1161/01.RES.0000016837.26733.BE
61. Forstermann U., Mulsch A., Bohme E., Busse R. (1986): Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ. Res. 58, 531-538
62. Funk D. J., Parrillo J. E., Kumar A. (2009): Sepsis and septic shock: a history. Crit. Care Clin. 25, 83-101; doi:10.1016/j.ccc.2008.12.003
63. Fujiki T., Shimokawa H., Morikawa K., Kubota H., Hatanaka M., Talukder M. A. H., Matoba T., Takeshita A., Sunagawa K. (2005): Endothelium-derived hydrogen peroxide accounts for the enhancing effect of an angiotensinconverting enzyme inhibitor on endothelium-derived hyperpolarizing factor-mediated responses in mice. Arteriosa. Thromb. Vasc. Biol. 25, 766-771 ; doi:10.1161/01.ATV0000158498.19027.75
64. Fulton D., Gratton J. P., Sessa W. C. (2001): Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 299, 818-824
65. Fulton D., Gratton J. P., McCabe T. J., Fontana J., Fujio Y., Walsh K., Franke T. F., Papapetropoulos A., Sessa W. C. (1999): Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601; doi:10.1038/21218
66. Furchgott R. F. (1988): Studies on relaxation of rabbit aorta by sodium nitrite the basis for the proposal that acid-activatible inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vasodilatation (Ed. P. M. Vanhoutte), pp. 401-412, Raven Press, New York
67. Furchgott R. F., Vanhoutte P. M. (1989): Endothelium-derived relaxing and contracting factors. FASEB J. 3, 2007-2018
68. Furchgott R. F., Zawadski J. V. (1980): The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 288, 373-376; doi:10.1038/288373a0
69. Garcia-Cardena G., Oh P., Liu J., Schnitzer J. E., Sessa W. C. (1996): Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. U. S. A. 93, 6448-6453; doi:10.1073/pnas.93.13.6448
70. Garthwaite J., Charles J. L., Chess-Williams R. (1988): Endo-thelium-derived relaxing factor release on activation of NMDA receptors suggests release intracellular messenger in the brain. Nature 336, 385-388; doi:10.1038/336385a0
71. Getz G. S. (1993): Report on the workshop on diabetes and mechanism of atherogenesis. Arterioscler. Thromb. 13, 459-464
72. Ghiadoni L., Mosca M., Tani C., Virdis A., Taddei S., Bombardieri S. (2008): Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. Clin. Exp. Rheumatol. 26, 680-687
73. Ginnan R., Guikema B. J., Halligan K. E., Singer H. A., Jourd'heuil D. (2008): Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic. Biol. Med. 44, 1232-1245; doi:10.1016/j.freeradbiomed.2007.12.025
74. Girard P., Potier P. (1993): NO, thiols and disulfides. FEBS Lett. 320,7-8; doi:10.1016/0014-5793(93)81645-G
75. Glovind J. S., Hartman J., Clemmensen K. E., Jessen K. E., Dan S. (1992): Studies of the role of lipoproteins in human pathology. Arch. Path. Microbiol. Scand. 30, 1-6; doi:10.1111/j.1699-0463.1952.tb00157.x
76. Godfraind T. Egleme C., Osachie I. A. (1985): Role of endothelium in the contractile response of rat aorta alfa-adrenoceptor agonists. Clin. Sci. 68, S65-71
77. Gold M. E., Wood K. S., Buga G. M., Byrus R. E., Ignarro L. J. (1989): L-arginine causes whereas L-arginine succinic acid inhibits endothelium dependent vascular smooth muscle relaxation. Biochem. Biophys. Res. Commun. 161, 536-543; doi:10.1016/0006-291X(89)92632-6
78. Gonzalez-Juanatey C., Llorca J., Miranda-Filloy J. A., Amigo-Diaz E., Testa A., Garcia-Porrua C., Martin J., Gonzalez-Gay M. A. (2007): Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 57, 287-293; doi:10.1002/art.22530
79. Gorbe A., Giricz Z., Szunyog A., Csont T., Burley D. S., Baxter G. R, Ferdinandy P. (2010): Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation. Basic Res. Cardiol. 105, 643-650; doi:10.1007/s00395-010-0097-0
80. Govers R., Rabelink T. J. (2001): Cellular regulation of endothelial nitric oxide synthase. Am. J. Physiol. Renal Physiol. 280, F193-206
81. Granger D. N. (1988): Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am. J. Physiol. 255, H1269-1275
82. Granger D. N. (1999): Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 6, 167-178 (Pubitemid 129671256)
83. Gratton J. P., Fontana J., O'Connor D. S., Garcia-Cardena G., McCabe T. J., Sessa W. C. (2000): Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90 and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J. Biol. Chem. 275, 22268-22272; doi:10.1074/;bc.M001644200
84. Grisham M. B., Granger D. N., Lefer D. L. (1998): Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Rad. Biol. 25,404-433; doi:10.1016/S0891-5849(98)00094-X
85. Gryglewski R. J., Palmer R. M. J., Moncada S. (1986): Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320, 454-456; doi:10.1038/320454a0
86. Gutterman D. D. (2002): Vascular dysfunction in hypertriglycemia. Is protein kinase C the culprit? Circ. Res. 90, 5-7
87. Hamilton S. J., Chew G. T., Watts G. F. (2007): Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diabetes Vase. Dis. Res. 4, 89-102; doi:10.3132/dvdr.2007.026
88. Hansel S., Lassig G., Pistrosch F., Passauer J. (2003): Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis 170, 177-180; doi:10.1016/S0021-9150(03)00281- 8
89. Harrison D. G., Widder J., Grumbach I., Chen W., Weber M., Searles C. (2006): Endothelial mechanotransduction, nitric oxide and vascular inflammation. J. Internal Med. 259, 351-363; doi:10.1111/j.1365-2796.2006.01621.x
90. Heistad D. D. (2008): Endothelial function in the time of the giants. J. Cardiovasc. Pharmacol. 52, 385-392; doi:10.1097/FJC.0b013e31818a403b
91. Heitzer T., Yla-Herttuala S., Luoma J., Kurz S., Munzel T., Just H., Olschewski M., Drexler H. (1996): Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93, 1346-1353 (Pubitemid 126425255)
92. Hennig B., Chow C. K. (1988): Lipid peroxidation and endothelial cell injury implications in atherosclerosis. Free Rad. Biol. Med. 4, 99-106; doi:10.1016/0891-5849(88)90070-6
93. Henry Y., Lepoivre M., Drapier J. C., Ducrocq C., Boucher J. L., Guissani A. (1993): EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7, 1124-1134. (Pubitemid 23271031)
94. Hingorani A. D., Cross J., Kharbanda R. K., Mullen M. J., Bhagat K., Taylor M., Donald A. E., Palacios M., Griffin G. E., Deanfield J. E., MacAllister R. J., Vallance P. (2000): Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102, 994-999
95. Hogan J. C., Lewis M. J., Hunderson A. H. (1988): In vivo EDRF activity influences platelet function. Brit. J. Pharmacol. 94, 1020-1022
96. Huang A., Sun D., Shesely E.G., Levee E.M., Koller A., Kaley G. (2002): Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice. Am. J. Physiol. Heart Circ. Physiol. 282, H429-436
97. Hunt J. V., Smith C. T., WolfS. P. (1990): Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39, 1420-1424; doi:10.2337/diabetes.39.11.1420
98. Hurlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., Bechir M., Spieker L. E., Neidhar M., Michel B. A., Gay R. E., Luscher T. F., Gay S., Ruschitzka F. (2002): Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106, 2184-2187; doi:10.1161/01.CIR.0000037521.71373.44
99. Ignarro L. J. (1990a): Biosynthesis and metabolism of endotheliumderived nitric oxide. Annu Rev. Pharmacol. Toxicol. 30, 535-560; doi:10.1146/annurev.pa. 30.040190.002535
100. Ignarro L. J. (1990b): Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension 16, 477-483
101. Ignarro L. J. (2000): The unique role of nitric oxide as a signaling molecule in the cardiovascular system. Ital. Heart J. 1 (Suppl. 3), S28-29
102. Ignarro L. J., Byrus R. E., Buga G. M., Wood K. S. (1987): Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties identical to those of nitric oxide radical. Circ. Res. 61, 866-879
103. Ignarro L. J., Byrns R. E., Wood K. S. (1988): Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide Radical. In: Vasodilatation (Ed. P. M. Vanhoutte), pp. 427-435, Raven Press, New York
104. Jiang Z. Y., Lin Y. W., Clemont A., Feener E. P., Hein K. D., Igarashi M., Yamauchi T., White M. F., King G. L. (1999): Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest. 104, 447-457; doi:10.1172/JCI5971
105. Johansson C. C., Mougiakakos D., Trocme E., All-Ericsson C., Economou M. A., Larsson O., Seregard S., Kiessling R. (2010): Expression and prognostic significance of iNOS in uveal melanoma. Int. J. Cancer 126, 2682-2689
106. Johns A., Lategan T. W., Lodge N. J., Ryan U. S., van Breemen C., Adams D. J. (1987): Calcium entry through receptor operated channels in bovine pulmonary artery endothelial cells. Tissue Cell 19, 733-745; doi:10.1016/0040-8166(87)90015-2 (Pubitemid 18028585)
107. Johns R. A., Linden J. M., Peach M. J. (1989): Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ. Res. 65, 1508-1515
108. Kaibori M., Sakitani K., Oda M., Kamiyama Y., Masu Y., Okumura T. (1999): Immunosuppressant FK56 inhibits iNOS gene expression at a step of NF-Kappa B activation in rat he patocytes. J. Hepatol. 30, 1138-1145; doi: 10.1016/S0168-8278(99)80270-0
109. Kanner J., Harel S., Grant R. (1991): Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289, 130-136; doi:10.1016/0003-9861(91)90452-0
110. Katušic Z. S., d'Uscio L.V., Nath K. A. (2008): Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. TIPS 30, 48-54
111. Katušic Z. S., Vanhoutte P. M. (1986): Anoxic contraction in isolated cerebral arteries. Contribution of endotheliumderived factors, metabolites of arachidonic acid and calcium entry. J. Cardiovasc. Pharmacol. 8 (Suppl. 8), S97-101;doi:10.1097/00005344-198600088-00020
112. Katušic Z. S., Vanhoutte P. M. (1989): Superoxide anion is an endothelium derived contracting factor. Amer. J. Physiol. 257, H33-37
113. Khanna A., Cowled P. A, Fitridge R. A. (2005): Nitric oxide and skeletal muscle reperfusion injury: Current controversies. J. Surg. Res. 128, 98-107
114. Kibbe M., Billiar T., Tzeng E. (1999): Inducible nitric oxide synthase and vascular injury. Cardiovasc. Res. 43, 650-657; doi:10.1016/S0008-6363(99) 00130-3
115. Kim J., Montagnani M., Koh K. K., Quon M. J. (2006): Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888-1904; doi:10.1161/CIRCU-LATIONAHA.105.563213 (Pubitemid 43739401)
116. Korthuis R. J., Gute D. C., Cepinska G., Kvietys P. R. (1998): Cellular mechanisms of acute versus delayed preconditioning. Pathophysiology 5, 35-48; doi:10.1016/S0928-4680(98)00007-8
117. Lamas S., Marsden P. A., Li G. K., Tempst P., Michel T. (1992): Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. U. S. A. 89, 6348-6352; doi:10.1073/pnas.89.14.6348
118. Lambert T. L., Kent R. S., Whorton A. R. (1986): Bradykinin stimulation of inositol polyphosphat production in porcine aortic endothelial cells. J. Biol. Chem. 261, 15288-15293
119. Lanas A. (2008): Role of nitric oxide in the gastrointestinal tract. Arthritis Res. Ther. 10 (Suppl. 2), 4-8; doi:10.1186/ar2465
120. Lefebvre R. A. (1995): Nitric oxide in the peripheral nervous system. Ann. Med. 27, 379-388; doi:10.3109/07853899509002591
121. Leloup C., Tourrel-Cuzin C., Magnan Ch., Karaca M., Castel J., Carneiro L., Colombani A. L., Ktorza A., Casteilla L., Penicaud L. (2009): Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 58, 673-681; doi:10.2337/db07-1056
122. Leung F. P., Yung L. M., Laher I., Yao X., Chen Z. Y., Huang Y. (2008): Exercise, vascular wall and cardiovascular diseases: an update (Part 1). Sports Med. 38, 1009-1024; doi:10.2165/00007256-200838120-00005
123. Leuris M. J., Hendersen A. H. (1987): A phorbolester inhibits the release of endothelium-derived relaxing factor. Eur. J. Pharmacol. 137, 167-171; doi:10.1016/0014-2999(87)90218-4
124. Loesch A., Burnstock G. (1998): Perivascular nerve fibres and endothelial cells of the rat basilar artery: immuno-gold labelling of antigenic sites for type I and type III nitric oxide synthase. J. Neurocytol. 27,197-204; doi:10.1023/A: 1026493425977 (Pubitemid 28253070)
125. Long C. J., Stone T. W. (1985): The release of endothelium derived relaxing factor is calcium dependent. Blood Vessels 22, 205-208 (Pubitemid 16217239)
126. Loscalzo J., Vita J. A. (2000): Nitric oxide and the cardiovascular system. Humana Press, Totowa, New Jersey; doi: 10.1385/1592590020
127. Lowenstein C. J., Dinerman J. L., Snyder S. H. (1994): Nitric oxide: a physiologic messenger. Annals Internal Med. 120, 227-237
128. Luo Z., Fujio Y., Kureishi Y., Rudic R. D., Daumerie G., Fulton D., Sessa W. C., Walsh K . (2000): Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J. Clin. Invest. 106, 493-499; doi:10.1172/JCI9419
129. Lüscher T. F. (1988): Pathophysiology of the vascular endothelium-hypertension. In: Endothelial Vasoactive Substances and Cardiovascular Disease (Ed. T. F. Lüscher), pp. 51-80, Karger, Sydney
130. Lüscher T. F. (1991): Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. Eur. Heart. J. 12 (Suppl. E), 2-11
131. Lüscher T. F., Baulanger Ch. M., Dali Y., Yang L. Ch. (1992): Endothelium-derived contracting factors. Hypertension 19, 117-130
132. Mackenzie I. S., Rutherford D., Mac Donald T. M. (2008): Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis. Arthritis Res. Ther. 10 (Suppl. 2), 3-14; doi:10.1186/ar2464
133. Makimattila S., Virkamaki A., Groop P. H., Cockcroft J., Utriainen T., Fagerudd J., Yki-Jarvinen H. (1996): Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 94, 1276-1282 (Pubitemid 26307253)
134. Maslov L. N., Kolar F., Barzakh E. I. (2009): Signaling mechanism of NO-induced increase in cardiac tolerance to ischemiareperfusion. Ross. Fiziol. Zh. Im. I. M. Sechenova 95, 1175-1189 (in Russian)
135. Matsunaga T., Nakajima T., Miyazaki T., Koyama I., Hokari S., Inoue I., Kawai S., Shimomura H., Katayama S., Hara A., Komoda T. (2003): Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cells. Metabolism 52, 42-49; doi:10.1053/meta.2003.50013
136. McEniery Yasmin C. M., Wallace S., Mackenzie I. S., Cockcroft J. R., Wilkinson I. B. (2004): C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler. Thromb. Vase. Biol. 24, 969-974; doi:10.1161/01.ATV.zhq0504.0173
137. Menardi A. C., Viaro F., Vicente W. V., Rodrigues A. J., Evora P. R. (2006): Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue. Arq. Bras. Cardiol. 87, 525-532
138. Mendelsohn M. E., Loscalzo J. (1992): The endotheliopathies. In: Vascular Medicine. 1st. ed. (Eds. J. Loscalzo, M. Creagher, V. J. Dzau), pp. 251-278, Little Brown, Boston
139. Miller D., Forrester K., Hart D. A., Leonard C., Salo P., Bray R. C. (2007): Endothelial dysfunction and decreased vascular responsiveness in the anterior cruciate ligament-deficient model of osteoarthritis. J. Appl. Physiol. 102, 1161-1169; doi:10.1152/japplphysiol.00209.2006
140. Moneada S., Palmer R. M. J., Higgs E. A. (1989): Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38, 1709-1715; doi:10.1016/0006-2952(89) 90403-6
141. Moncada S., Palmer R. M. J., Higgs, E. A. (1991): Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142
142. Mugge A., Forsterman U., Lichtlen P. R. (1989): Endothelial functions in cardiovascular diseases. Z. Kardiol. 78, 147-160 (in German)
143. Muijsers R. B. R., Folkerts G., Henricks P. A. J., Sadeghi-Hashjin G., Nijkamp F. P. (1997): Peroxynitrite: a two-faced metabolite of nitric oxide. Life Sci. 60, 1833-1845; doi:10.1016/S0024-3205(96)00651-0 (Pubitemid 127363080)
144. Murad F., Mittal C. K., Arnold W. P., Katsuki S., Kimura H. (1978): Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv. Cyclic Nucleotide Res. 9, 145-158
145. Muscogiuri G., Chavez A. O., Gastaldelli A., Perego L., Tripathy D., Saad M. J., Velloso L., Folii F. (2008): The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. Curr. Vasc. Pharmacol. 6, 301-312; doi:10.2174/157016108785909715
146. Mülsch A., Mordvintcev P., Vanin A., Busse R. (1993): Formation and release of dinitrosyl iron complexes by endothelial cells. Biochem. Biophys. Res. Commun. 196, 1303-1308; doi:10.1006/bbrc.1993.2394
147. Münzel T. (2008): Endothelial dysfunction: pathophysiology, diagnosis and prognosis. Dtsch. Med. Wochenschr. 133, 2465-2470 (in German); doi:10.1055/s-0028-1100941
148. Myers P. R., Minor R. L., Guerra R. Jr., Bates J. N., Harrison D. G. (1990): Vasorelaxant properties of the endotheliumderived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345, 161-163; doi:10.1038/345161a0
149. Nakashidze I. M. (2009): The changes of content of TNF-alpha, nitric oxide and FeS-NO in patients blood with traumatic shock under Plaferon LB influence. Georgian Med. News. 171, 76-78 (in Russian)
150. Nathanson D., Nyström T. (2009): Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium. Mol. Cell. Endocrinol. 297, 112-126; doi:10.1016/j.mce.2008.11.016
151. Neary P., Redmond H. P. (1999): Ischaemia-reperfusion injury and the systemic inflammatory response syndrome. In: Ischemia-Reperfusion Injury (Eds. P. A. Grace, R. T. Mathie), pp. 123-136, Blackwell Science, London
152. Noack E., Feelisch M. (1989): Molecular aspects underlying the vasodilator action of molsidomin. J. Cardiovasc. Pharmacol. 14, S1-5; doi:10.1097/00005344-198906152-00002
153. Nosálbvá V., Navarová J., Mihalová D., Sotníková R. (2007): Mesenteric ischemia/reperfusion-induced intestinal and vascular damage: effect of stobadine. Meth. Find. Exp. Clin. Pharmacol. 29, 39-45; doi:10.1358/mf.2007.29.1.1063495
154. Oess S., Icking A., Fulton D., Govers R., Muller-Esterl W. (2006): Subcellular targeting and trafficking of nitric oxide synthases. Biochem. J. 396, 401-409; doi:10.1042/BJ20060321 (Pubitemid 44228155)
155. Pacher P., Beckman J. S., Liaudet L. (2007): Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424; doi:10.1152/physrev.00029.2006
156. Pacher P., Szabo C. (2008): Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease. Am. J. Pathol. 173, 2-13; doi:10.2353/ajpath.2008.080019
157. Palinski W., Rosenfeld M. E., Yla-Herruala S., Gurtner G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., Witztum J. L. (1989): Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. U.S.A. 86, 1371-1375; doi:10.1073/pnas.86.4.1372
158. Palmer R. M. J., Ashton D. S., Moneada S. (1988): Vascular endothelial cells synthetises nitric oxide from L-arginine. Nature 333, 664-666; doi:10.1038/333664a0
159. Palmer R. M. J., Ferrige A. G., Moncada S. (1987): Nitric oxide release accounts for the biological activity of edothelium-derived relaxing factor. Nature 327, 524-526; doi:10.1038/327524a0
160. Parratt J. R. (1998): Nitric oxide in sepsis and endotoxemia. J. Antimicrobial Chemotherapy 41 (Suppl. A), 31-39; doi:10.1093/jac/41.suppl-1.31
161. Pasceri V., Willerson J. T., Yeh E. T. (2000): Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102, 2165-2168
162. Patil C. S., Singh V. P., Kulkami S. K. (2006): Modulatory effect of sildenafil in diabetes and electroconvulsive shockinduced cognitive dysfunction in rats. Pharmacol. Rep. 58, 373-380
163. Peinado V. I., Pizarro S., Barbera J. A. (2008): Pulmonary vascular involvement in COPD. Chest 134, 808-814; doi:10.1378/chest.08-0820
164. Pieper G. M., Gross G. R. (1991): Endothelial dysfunction in diabetes. In: Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. 1st. ed. (Ed. G. M. Rubanyi), pp. 223-249, Futura, Mount Kisco, New York
165. Piper M. K., Raza K., Nuttall S. L., Stevens R., Toescu V., Heaton S., Gardner-Medwin J., Hiller L., Martin U., Townend J., Bacon P.A., Gordon C. (2007): Impaired endothelial function in systemic lupus erythematosus. Lupus 16, 84-88; doi:10.1177/0961203306074842 (Pubitemid 46347929)
166. Piotrowski J. J., Hunter G. C., Eskelson C. D., Dubick M. A., Berhard V. M. (1990): Evidence for lipid peroxidation in atherosclerosis. Life Sci. 46, 715-721 ; doi:10.1016/0024-3205(90)90077-5
167. Potenza M. A., Gagliardi S., Nacci C., Carratu M. R., Montagnani M. (2009): Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr. Med. Chem. 16, 94-112; doi:10.2174/092986709787002853
168. Potenza M. A., Montagnani M. (2008): Abnormal insulin signaling: early detection of silent coronary artery disease erectile dysfunction? Curr. Pharm. Des. 14, 3737-3748; doi.10.2174/138161208786898707
169. Prasad A., Andrews N. P., Padder F. A., Husain M., Quyyumi A. A. (1999): Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability. J. Am. Coll. Cardiol. 34, 507-514; doi: 10.1016/S0735-1097(99) 00216-8
170. Radomski M. C., Palmer R. M. J., Moneada S. (1987): Comparative pharmacology of endothelium derived relaxing factor, nitric oxide and prostacyclin in platelets. Brit. J. Pharmacol. 92, 181-187
171. Raitakari O. T., Adams M. R., McCredie R. J., Griffiths K. A., Stocker R., Celermajer D. S. (2000): Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. J. Am. Coll. Cardiol. 35, 1616-1621; doi : 10.1016/S0735-1097(00)00576-3
172. Rappoport R. M., Murad F. (1983): Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ. Res. 52, 352-357
173. Rappoport R. M., Draznin M. B., Murad F. (1983): Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306, 174-176; doi:10.1038/306174a0
174. Redington A. E. (2006): Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. Eur. J. Pharmacol. 533, 263-276; doi:10.1016/j.ejphar.2005.12.069
175. Rembold Ch. M. (1992): Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 20, 129-137
176. Ress D. D., Palmer R. M. J., Hodson H. F., Moneada S. (1989): A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Brit. J. Pharmacol. 96, 418-424
177. Roks A. J. M. (2002): Improvement of endothelium-derived hyperpolarizing factor function by renin-angiotensin system inhibition: paving the way towards prevention of age-related endothelial dysfunction. J. Hypertension 20, 363-365; doi:10.1097/00004872-200203000-00005
178. Ross R. (1993): The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809; doi:10.1038/362801a0
179. Ross R. (1999): Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126; doi:10.1056/NEJ-M199901143400207
180. Rubanyi G. M. (1988): Vascular effect of oxygen-derived free radicals. Free Rad. Biol. Med. 4,107-120; doi:10.1016/0891-5849(88)90071-8
181. Rubanyi G. M. (1991a): Endothelium derived relaxing and contracting factors. J. Cell Biochem. 46, 27-36; doi:10.1002/jcb.240460106
182. Rubanyi G. M. (1991b): Cardiovascular significance of endothelium-derived vasoactive factors. Futura, Mount Kisco, New York
183. Rubanyi G. M., Johns A., Harrison D. G., Wilcox D. (1989): Evidence that EDRF may be identical with an 5-nitrothiol and not with free nitric oxide. Circulation 80 (Suppl. 2), 276-281
184. Rubanyi G. M., Ho E., Canta E. H., Lumma W. C., Botello L. H. P. (1991): Cytoprotective function of nitric oxide. Inactivation of superoxide radicals produced by human leukocytes. Biophys. Res. Commun. 181, 1392-1397; doi:10.1016/0006-291X(91)92093-Y
185. Rubanyi G. M., Vanhoutte P. M. (1985): Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J. Physiol. (London) 364, 45-56
186. Rubanyi G. M., Vanhoutte P. M. (1986a): Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Amer. J. Physiol. 250, H815-821
187. Rubanyi G. M., Vanhoutte P. M. (1986b): Superoxide anion and hypoxia inactivate endothelium derived relaxing factor. Amer. J. Physiol. 250, H822-827
188. Rumley A. G., Woodward M., Rumley A., Rumley J., Lowe G. D. (2004): Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease. Q. J. Med. 97, 809-816
189. Ryan U. S. (1989): Endothelium as transducing surface. J. Mol. Cell Cardiol. 21 (Suppl. 1), 85-90; doi:10.1016/0022-2828(89)90841-9
190. Sanders D. B, Kelley T., Larson D. (2000): The role of nitric oxide synthase/nitric oxide in vascular smooth muscle control. Perfusion 15, 97-104 (Pubitemid 30182409)
191. Sari I., Okan T., Akar S., Cece H., Altay C., Secil M., Birlik M., Onen F., Akkoc N. (2006): Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45, 283-286; doi:10.1093/rheumatology/kei145
192. Schmidt K., Greier W. F., Kostner G. M., Mayer B., Bohme E., Kukovetz W. R. (1992): Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor is antagonized by oxidized low density lipoprotein. J. Cardiovasc. Pharmacol. 17 (Suppl. 3), S83-88; doi:10.1097/00005344-199117003- 00015
193. Schödela J., Padmapriyaa P., Marxb A., Huangc P. L., Ertl G., Kuhlencordt P. J. (2009): Expression of neuronal nitric oxide synthase splice variants in atherosclerotic plaques of apoE knockout mice. Atherosclerosis 206, 383-389; doi:10.1016/j.atherosderosis.2009.02.033
194. Sena C. M., Seica R. M. (2010): Oxidative stress and endothelial dysfunction: novel therapeutic interventions. In: Advances in Molecular Mechanisms and Pharmacology of Diabetic Complications. (Ed. M. Stefek), Transworld Research Network, 37/661 (2), Fort P.O.Trivandrum-695 023 Kerala, India (In press)
195. Shi H. P., Wang S. M., Zhang G. X., Zhang Y. J., Barbul A. (2007): Supplemental L-arginine enhances wound healing following trauma/hemorrhagic shock. Wound Repair Regen. 15, 66-70; doi:10.1111/j.1524-475X.2006.00186.x
196. Shimokawa H., Matoba T. (2004): Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol Res. 49,543-549; doi:10.1016/j.phrs.2003.10.016 (Pubitemid 38338664)
197. Singer H. A., Peach M. J. (1982): Calcium and endothelial mediated vascular smooth relaxation in rabbit aorta. Hypertension 4 (Suppl. 2), 19-25
198. Spinetti G., Kraenkel N., Emanueli C., Madeddu P. (2008): Diabetes and vessel wall remodeling: from mechanistic insights to regenerative therapies. Cardiovasc. Res. 78, 265-273; doi:10.1093/cvr/cvn039
199. Stabile A.M., Moreto V., Antunes-Rodrigues J., Carnio E.C. (2010): Central but not systemic inhibition of inducible nitric oxide synthase modulates oxytocin release during endotoxemic shock. Peptides 31, 706-711; doi:10.1016/j.peptides.2009.11.004
200. Stam H., Hulsmann W. C., Jonkid J. F., Van der Kraaij A. M., Koster J. F. (1989): Endothelial lesions, dietary composition and lipid peroxidation. Eicosanoids 2, 1-14
201. Stanfield C. M., Schilling W. P., Possami L. D., Kunze D. L. (1990): Bradykinin-induced potassium current in culture bovine aortic endothelial cells. J. Neur. Biol. 116, 227-238
202. Stankevičius E., Kevelaitis E., Vainorius E., Simonsen U. (2003): Role of nitric oxide and other endothelium-derived factors. Medicina 39, 333-341
203. Stawicki S. P., Sims C., Sarani B., Grossman M. D., Gracias V. H. (2008): Methylene blue and vasoplegia: who, when, and how? (Mini Rev.), Med. Chem. 8, 472-490
204. Steinberg D., Parthasarathy S., Carev T. E., Khao J. C., Witztum J. L. (1989): Beyond cholesterol: Modification of low density lipoprotein that increased its atherogenicity. N. Engl. J. Med. 320, 915-924
205. Stocker R., Keaney J. F. Jr. (2004): Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478; doi:10.1152/physrev.00047.2003
206. Sullivan J. C., Pardieck J. L., Hyndman K. A., Pollock J. S. (2010): Renal NOS activity, expression, and localization in male and female spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R61-69; doi:10.1152/ajpregu.00526.2009
207. Suzuki M., Ohyama Y., Satoh S. (1984): Conversion of angiotensin I to angiotensin II and inactivation of bradykinin in canine peripheral vascular beds. J. Cardiovasc. Pharmacol. 8, 244-250; doi:10.1097/00005344-198403000-00006
208. Szekanecz Z., Koch A. E. (2008): Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res. Ther. 10, 224-234; doi:10.1186/ar2515
209. Taddei S., Virdis A., Mattei P., Ghiadoni L., Gennari A., Fasolo C., Sudano I., Salvetti A. (1995): Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91, 1981-1987
210. Takei A., Huang Y., Lopes-Virella F. (1998): Intercellular adhesion molecule- 1 (ICAM-1 ) expression induced by oxLDL on human umbilical vein endothelial cells (HUVEC) depends on the stage of LDL oxidation. Diabetes 47, (Suppl.1), A115
211. Takala H., Saarnio J., Wiik H., Ohtonen P., Soini Y. (2010): HIF-1 alpha and VEGF are associated with disease progression in esophageal carcinoma. J. Surg. Res. (Epub. ahead of print, 2010 Mar 19)
212. Tesfamariam B. (1994): Free radicals in diabetic endothelial cell dysfunction. Free Rad. Biol. Med. 16, 383-391; doi:10.1016/0891-5849(94)90040-X
213. Toda N., Herman A. G. (2005): Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol. Rev. 57, 315-338; doi:10.1124/pr.57.3.4
214. Toda N., Ayajiki K., Okamura T. (2007): Interaction of endothelial nitric oxide and angiotensin in the circulation. Pharmacol. Rev. 59, 54-87; doi:10.1124/pr.59.1.2
215. Toda N., Okamura T. (2003): The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol. Rev. 55, 271-324; doi:10.1124/pr.55.2.3
216. Tripathi P., Misra M. K. (2009): Therapeutic role of L-arginine on free radical scavenging system in ischemic heart diseases. Indian J. Biochem. Biophys. 6, 498-502
217. Trouillon R., Cheung C., Patel B. A., O'Hare D. (2010): Electrochemical study of the intracellular transduction of vascular endothelial growth factor induced nitric oxide synthase activity using a multi-channel biocompatible microelectrode array. Biochim. Biophys. Acta 1800, 929-936
218. Tsai S. K., Lin S. M., Huang C. H., Hung W. C., Chih C. L., Huang S. S. (2004): Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits. Life Sci. 76, 651-660; doi:10.1016/j.lfs.2004.05.025
219. Tsutsui M. (2004): Neuronal nitric oxide synthase as a novel antiatherogenic factor. J. Atheroscler. Thromb. 11, 41-48
220. Upchurch G. R. Jr., Ford J. W., Weiss S. J., Knipp B. S., Peterson D. A., Thompson R. W., Eagleton M. J., Broady A. J., Proctor M. C., Stanley J. C. (2001): Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro. J. Vasc. Surg. 34, 76-83; doi:10.1067/mva.2001.115598
221. Vanderjagt D. J., Harrison J. M., Ratliff D. M., Hunsaker L. A., Vanderjagt D. L. (2001): Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin. Biochem. 34, 265-270; doi:10.1016/S0009-9120(01)00204-1
222. Vane J. R. (1994): The croonian lecture, 1993. The endothelium: maestro of the blood circulation. Biol. Sci. 343, 225-246; doi:10.1098/rstb.1994.0023
223. Vane J. R., Änggard E. E., Botting R. M. (1990): Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323, 27-36; doi:10.1056/NEJM199007053230106
224. Van Hinsbergh V. W. M. (1988): Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. Haemostasis 18, 307-327
225. Vanhoutte P. M. (1988): The endothelium: modulator of vascular smooth muscle tone. N. Engl. J. Med. 319, 512-513; doi:10.1056/NEJM198808253190809
226. Vanhoutte P. M. (1992): Role of calcium and endothelium in hypertension, cardiovascular disease and subsequent vascular events. J. Cardiovasc. Pharmacol. 19 (Suppl. 3), S6-10
227. Vanhoutte P. M., Eber B. (1991): Endothelium-derived relaxing and contracting factors. Wien. Klin. Wochenschr. 103, 405-411
228. Vanhoutte P. M., Hauston D. S. (1985): Platelets, endothelium and vasospasm. Circulation 71, 728-734
229. Vanhoutte P. M., Lüscher T. F., Graser T. (1991): Endothelium dependent contractions. Blood Vessels 28, 74-83
230. Vareniuk I., Pacher P., Pavlov I. A., Drei V. R., Obrosova I. G. (2009): Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency. Int. J. Mol. Med. 23, 571-580
231. Walsh T., Donnelly T., Lyons D. (2009): Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension, and atherogenesis? J. Am. Geriatr. Soc. 57, 140-145; doi:10.1111/j.1532-5415.2008.02051.x
232. Wang W, Viappiani S., Sawicka J., Schulz R. (2005): Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release. Br. J. Pharmacol. 145, 43-49; doi:10.1038/sj.bjp.0706144
233. Weinberg J. B., Fermor B., Guilak F. (2007): Nitric oxide synthase and cyclooxygenase interactions in cartilage and meniscus: relationships to joint physiology, arthritis, and tissue repair. Subcell. Biochem. 42, 31-62; doi:10.1007/1-4020-5688-5-2
234. Wilcox J. N., Subramanian R. R., Sundell C. L., Tracey W.R., Pollock J. S., Harrison D. G. Marsden P. A. (1997): Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscl. Thromb.Vasc. Biol. 17, 2479-2488
235. Wittmeyer V., Merrot T., Mazet B. (2010): Tonic inhibition of human small intestinal motility by nitric oxide in children but not in adults. Neurogastroenterol. Motil. (Epub ahead of print, 2010 Jun 11)
236. Wolf S. P., Jiang Z. Y., Hunt J. V. (1991): Protein glycation and oxidative stress in diabetes melitus and aging. Free Rad. Biol. Med. 10, 339-352; doi:10.1016/0891-5849(91)90040-A
237. Wong A. Y. K., Klassen G. A. (1992): A model of cytosolic calcium regulation and autocoids production in vascular endothelial cells. Basic. Res. Cardiol. 87, 317-332; doi:10.1007/BF00796518
238. Yanagisawa M., Kurikaza H., Kimura S., Tomobe Y., Kobyoshi M., Mitsui Y., Yzaki Y., Goto K., Masaki T. (1988): A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415; doi:10.1038/332411a0 (Pubitemid 18090241)
239. Yang X., Cai B., Sciacca R. R., Cannon P. J. (1994): Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circulat. Res. 74, 318-328
240. Young J. C., Schneiderm C., Hartl F. U. (1997): In vitro evidence that hsp90 contains two independent chaperone sites. FEBS Lett. 418, 139-143; doi:10.1016/S0014-5793(97)01363-X
241. Zawadski J. V., Chery P. D., Furchgott R. F. (1980): Comparison of endothelium-derived relaxations of rabbit aorta by A23187 and acetylcholine. Pharmacologist 22, 271-275
242. Zhang Z. Y., Zhang Z., Schluesener H. J. (2010): MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis. Neuroscience 169, 370-377; doi:10.1016/j.neuroscien-ce. 2010.04.074
243. Zou M. H., Shi C., Cohen R. A. (2002): Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109, 817-826